Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 12/20 | 1.00 |
| ▸ | CNR1 | P21554 | 10/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 1/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 1.00 |
| ▸ | PPARG | P37231 | 4/20 | 0.64 |
| ▸ | PPARD | Q03181 | 4/20 | 0.64 |
| ▸ | PPARA | Q07869 | 4/20 | 0.64 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4880981 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL30698242 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL1031361 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL1030239 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL1030994 | 0.94 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL1030779 | 0.94 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL28661229 | 0.94 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL26127030 | 0.92 | CNR2 (0.97) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL27171367 | 0.88 | CNR2 (0.78) | CNR2CNR1TRPA1TRPV1PPARG | |
| SCHEMBL31228767 | 0.87 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250380732-A1 | AEROSOLISABLE FORMULATION | NICOVENTURES TRADING LTD (GB) | 2025-12-18 | — | — | US | disclosed |
| US-20250241356-A1 | ORAL COMPOSITION COMPRISING RECEPTOR MODULATOR | DANIEL MICHAEL S (US) | 2025-07-31 | — | — | US | disclosed |
| EP-4543230-A1 | AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023247962-A1 | AEROSOLISABLE FORMULATION | Nicoventures Trading Limited (GB) | 2023-12-28 | — | — | WO | disclosed |